Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Sanara MedTech (SMTI) over the last 9 years, with Q3 2025 value amounting to -$3.4.

  • Sanara MedTech's EPS (Weighted Average and Diluted) fell 90000.0% to -$3.4 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.22, marking a year-over-year decrease of 32626.26%. This contributed to the annual value of -$1.16 for FY2024, which is 11586.63% down from last year.
  • Latest data reveals that Sanara MedTech reported EPS (Weighted Average and Diluted) of -$3.4 as of Q3 2025, which was down 90000.0% from -$0.23 recorded in Q2 2025.
  • In the past 5 years, Sanara MedTech's EPS (Weighted Average and Diluted) registered a high of $0.09 during Q2 2022, and its lowest value of -$3.4 during Q3 2025.
  • In the last 4 years, Sanara MedTech's EPS (Weighted Average and Diluted) had a median value of -$0.22 in 2023 and averaged -$0.5.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first surged by 9397.99% in 2023, then plummeted by 250382.91% in 2024.
  • Sanara MedTech's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.53 in 2022, then skyrocketed by 93.98% to -$0.03 in 2023, then plummeted by 2503.83% to -$0.83 in 2024, then plummeted by 311.91% to -$3.4 in 2025.
  • Its EPS (Weighted Average and Diluted) was -$3.4 in Q3 2025, compared to -$0.23 in Q2 2025 and -$0.41 in Q1 2025.